hematoxylin has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alsaleem, M; Green, AR; Lashen, A; Mongan, NP; Rakha, E; Toss, MS | 1 |
| Akarca, A; Alaguthurai, T; Buus, R; Cheang, M; Dowsett, M; Gazinska, P; Gillett, C; Graham, R; Haider, S; Iacovacci, J; Irshad, S; Khan, A; Lips, E; Marafioti, T; Melcher, A; Milton, C; Naidoo, K; Roxanis, I; Salgado, R; Tutt, A; Ward, J; Wesseling, J; Wu, Y | 1 |
| Basset, R; Huang, W; Jain, P; Krishnamurthy, S; Kummar, S; Muhammad, H; Randhawa, R; Roy, R; Tripathy, D; Wilding, G; Yang, H | 1 |
3 other study(ies) available for hematoxylin and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
The characteristics and clinical significance of atypical mitosis in breast cancer.
Topics: Breast Neoplasms; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Mitosis; Prognosis; Triple Negative Breast Neoplasms | 2022 |
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers.
Topics: B7-H1 Antigen; Breast Neoplasms; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Neoadjuvant Therapy; Neutrophils; Programmed Cell Death 1 Receptor; RNA, Messenger; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2022 |
Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network-Based Artificial Intelligence Tool.
Topics: Artificial Intelligence; Eosine Yellowish-(YS); Hematoxylin; Humans; Neoadjuvant Therapy; Neural Networks, Computer; Triple Negative Breast Neoplasms | 2023 |